These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

971 related items for PubMed ID: 10874062

  • 1. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G.
    N Engl J Med; 2000 Jun 29; 342(26):1946-52. PubMed ID: 10874062
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
    Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihara K.
    Clin Cancer Res; 2003 Oct 15; 9(13):4756-60. PubMed ID: 14581346
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
    Prescrire Int; 2006 Feb 15; 15(81):13-5. PubMed ID: 16548099
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ.
    N Engl J Med; 2002 Dec 26; 347(26):2104-10. PubMed ID: 12501222
    [Abstract] [Full Text] [Related]

  • 5. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC, Familial Adenomatous Polyposis Study Group.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 26; 13(6):920-7. PubMed ID: 15184247
    [Abstract] [Full Text] [Related]

  • 6. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA.
    Cancer Res; 2000 Sep 15; 60(18):5040-4. PubMed ID: 11016626
    [Abstract] [Full Text] [Related]

  • 7. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
    Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G, FAP Study Group.
    Gut; 2002 Jun 15; 50(6):857-60. PubMed ID: 12010890
    [Abstract] [Full Text] [Related]

  • 8. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Sheng JQ, Li SR, Yang XY, Zhang YH, Su H, Yu DL, Yan W, Geng HG.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):526-9. PubMed ID: 16681880
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
    Lynch PM, Ayers GD, Hawk E, Richmond E, Eagle C, Woloj M, Church J, Hasson H, Patterson S, Half E, Burke CA.
    Am J Gastroenterol; 2010 Jun 28; 105(6):1437-43. PubMed ID: 20234350
    [Abstract] [Full Text] [Related]

  • 10. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS.
    Mayo Clin Proc; 1999 Nov 28; 74(11):1095-105. PubMed ID: 10560596
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B, PreSAP Trial Investigators.
    N Engl J Med; 2006 Aug 31; 355(9):885-95. PubMed ID: 16943401
    [Abstract] [Full Text] [Related]

  • 12. Arthritis drug approved for polyp prevention blazes trail for other prevention trials.
    Smigel K.
    J Natl Cancer Inst; 2000 Feb 16; 92(4):297-9. PubMed ID: 10675374
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of celecoxib, a COX-2 inhibitor, in familial adenomatous polyposis].
    Wullen B, Mühlhöfer A, Zoller WG.
    Z Gastroenterol; 2001 Apr 16; 39(4):335-7. PubMed ID: 11367984
    [No Abstract] [Full Text] [Related]

  • 14. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
    Chau I, Cunningham D.
    N Engl J Med; 2002 Apr 04; 346(14):1085-7. PubMed ID: 11932478
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
    Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H.
    Arthritis Rheum; 2001 Jan 04; 44(1):180-5. PubMed ID: 11212158
    [Abstract] [Full Text] [Related]

  • 17. Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.
    Davies NM, Gudde TW, de Leeuw MA.
    Expert Opin Pharmacother; 2001 Jan 04; 2(1):139-52. PubMed ID: 11336575
    [Abstract] [Full Text] [Related]

  • 18. [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
    Rioda WT, Nervetti A.
    Acta Biomed Ateneo Parmense; 2001 Jan 04; 72(3-4):55-64. PubMed ID: 11889908
    [Abstract] [Full Text] [Related]

  • 19. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
    Ta LE, Dionne RA.
    Pain; 2004 Sep 04; 111(1-2):13-21. PubMed ID: 15327804
    [Abstract] [Full Text] [Related]

  • 20. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    Scand J Rheumatol Suppl; 1999 Sep 04; 109():31-7. PubMed ID: 10422544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.